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Persistent dyspnea, declined moderate to vigorous physical activity, functional
status, and quality of life during the post-acute phase of COVID-19 infection: A
pilot case control study.
Abstract
Abstract
Purpose: The purpose of this study was to explore the multifaceted impacts of post-acute phase of
COVID-19 infection on the sense of dyspnea, select intensities of physical activity, functional, and
psychological variables among survivors compared to age matched healthy participants and their
implications for rehabilitation programs in this population.
Methods: Seventy-eight (male, female age 30-70 yrs.) participants (39 COVID-infected, CI and 39 agematched healthy controls, HC). Four questionnaires were used to assess the variables in this study:
dyspnea scale of the Modified Medical Research Council (mMRC), International Physical Activity
Questionnaire (IPAQ), Functional Status Questionnaire (FSQ), and the RAND-36 measure of health-related
quality of life. A Mann Whitney test was used to compare the variables data between HC and CI.
Results: Dyspnea scores in CI group were significantly higher than in HC group (mean = 1.77 vs 0.13).
Scores of IPAQ, FSQ and RAND-36 HRQoL questionnaires were also significantly lower in CI than in HC
group. However, sitting and walking activity scores of IPAQ were not significantly different between both
groups.
Conclusions: The results of the CI group were significantly different than the HC group in all parameters
(except sitting and walking components of the IPAQ) of the questionnaires used in this study. Our findings
provide the multi-disciplinary rehabilitation professionals the opportunity to tailor their interventions to
meet the specific needs of COVID-19 survivors.

Keywords
COVID-19, dyspnea, physical activity, functional status, quality of life

This article is available in NeuroSports: https://nsuworks.nova.edu/neurosports/vol1/iss1/10

Aslan et al.: Persistent symptoms and physical limitations post-acute COVID-19 infection

Introduction
The symptoms of COVID-19 infection appear after a period of incubation that lasts
approximately 5.2 days (Li et al., 2020; Rothan & Byrareddy, 2020). Common
symptoms include fever, cough, and general weakness along with other symptoms
including vomiting, headache, sputum production, haemoptysis, diarrhoea,
dizziness, chest tightness and dyspnea (Huang et al., 2020; Ren et al., 2020; Shi et
al., 2020). According to Shi et al. (2020), dyspnea is among the most common
symptoms in these individuals. While the cause of dyspneic symptoms remains
poorly understood to date, predominant theories suggest diffuse lung injury,
pulmonary inflammation, interstitial edema, and microvascular pulmonary
thrombosis are likely responsible (Cascella et al., 2020; Menter et al., 2020; Rubin
& Crowe, 2020). In addition, some patients may also present with severe
cardiovascular damage (Zheng et al., 2020), neurological concerns such as
headache, dizziness, myalgia and/or fatigue, anomia, anorexia, ageusia (Chen et al.,
2020; Gupta et al., 2020; Huang et al., 2020), and in some severe cases,
presentations such as confusion, and impaired consciousness are also reported
(Mao et al., 2020; Pilotto et al., 2020). Furthermore, some patients experience
debilitating muscle weakness that occurs particularly in the presence of an acute
hospitalization stay (Bagnato et al., 2020; Xiong et al., 2021). Similar to the
presentation of acute respiratory distress syndrome, it can be expected that these
symptoms may last long into the post-acute care rehabilitation period and contribute
to lasting functional decline (Bagnato et al., 2020; De Biase et al., 2020; Herridge
et al., 2003; O’Donnell et al., 2019; Pfoh et al., 2016; Woods et al., 2020; Xiong et
al., 2021).
It is estimated that 50% of COVID-19 survivors will require some form of
medical or social care including rehabilitation for a long period of time after
recovery from the initial illness (Thornton, 2020). Rehabilitation services for
COVID-19 survivors generally take five forms: exercise to improve
cardiorespiratory fitness; performing functional activities; psychosocial
interventions; education/self-management; and personalized actions to meet
survivors’ specific needs (Farkash et al., 2020; Wade, 2020b). During the postacute phase of COVID-19 infection, fatigue, exertional dyspnea and significant
cardiac diastolic abnormalities were the most reported common symptoms after 180
days of discharge from hospital among the survivors of the virus (Fayol et al., 2021;
Q. Wu et al., 2021). It has been also reported that after 2-3 days post infection date
of COVID-19, 64% of the recovered patients experienced dyspnea and 55%
experienced fatigue (Raman et al., 2021).
To date, available literature has reported rehabilitation needs in general
terms to address breathlessness, neuropsychological, speech, pain, fatigue,
nutrition, daily activities and health-related quality of life among other concerns
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(Halpin et al., 2021; Wade, 2020a). As the pandemic continues, more investigations
are needed to identify the specific rehabilitation needs and the length of
rehabilitation programs for the survivors of the COVID-19. Therefore, there is a
lack of studies investigating the multifaceted impact of post-acute phase of COVID19 infection on the ability to perform different intensities of physical activities,
functional status, and quality of life parameters when compared to aged-matched
healthy control sample groups. This latter point is specifically important because
healthy individuals are also exposed to pandemic-related restrictions and concerns
that can also negatively affect their physical and psychosocial wellbeing (Ammar
et al., 2020; Hossain et al., 2020). Therefore, the purpose of this study was to
explore the multifaceted impacts of post-acute phase of COVID-19 infection on the
sense of dyspnea, select intensities of physical activity, functional, and
psychological variables among survivors compared to age matched healthy
participants and their implications for rehabilitation programs in this population.
We hypothesized that COVID-19 infected participants will have deficits in
physical, functional performance and some psychological parameters compared
with age-matched healthy controls.
Methods
Study design and participants
This was an observational case control cohort study, whereby we recruited
participants both with (COVID infected or CI) and without (Healthy Control or
HC) a prior diagnosis of COVID-19 infection by word of mouth through posts on
social media for a period of two months (October 20th-December 20th, 2020). Due
to the limitation set by the pandemic itself, data was collected using a sample of
convenience via an online survey. The participants in this study were from five
different countries (3 continents) around the world and not limited to Canadians
only (n=CA=30, USA=4, UK=3, Iran=1, and Thailand=1). The global participation
formed 23% of the total number of the participants. Consenting participants
completed an online survey using 4 standardized questionnaires (detailed below).
The responses of the participants in both groups to the 4 questionnaires reflected
their status at the time of taking the survey and not at the time of infection (i.e.,
time of infection for CI group only). All cases of infection among the infected
participants with COVID-19 were self-reported (i.e., medically diagnosed with
positive COVID-19 test). Since the median time from the date of COVID-19
infection and clinical recovery in mild-severe cases is about 2-4 weeks (Callard &
Perego, 2021; Greenhalgh et al., 2020), all our infected participants can be
considered in their post-acute phase. This study was approved by the University of
Saskatchewan Research Ethics Board (Bio-REB ID: 2312).
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Inclusion criteria stated that any individual who survived the COVID-19
infection (male and female) between 30-70 years can participate in this study. The
rationale behind choosing this age range was based on an epidemiological summary
findings (n = 8 614) in Canada showed that individuals at age ranges (40-59, 20-39
and 60-79 years-old) had the highest infection cases (35%), (28%) and (24%),
respectively (Notes, 2020). For the healthy control group, subjects were agematched (30-70 years) but not gender-matched due to difficulties of recruiting
participants and the time-sensitive nature of the current study. Participants with preexisting chronic cardiovascular, pulmonary (other than being infected with
COVID-19 and survived the illness for the infected group), musculoskeletal
disorders were excluded from starting the study. Questionnaires were delivered
electronically (SurveyMonkey Inc., San Mateo, California, USA) to participants
following digital provision of informed consent. To ensure attaining reliable and
accurate data (i.e., responses) from the participants, a detailed instruction on how
to complete the survey were provided both in the consent form and before giving
their responses in each section in each questionnaire used in the survey. In addition,
participants were instructed to ask any questions on how to complete the survey
from the research team via email or direct phone calls before taking the survey.
Modified Medical Research Council Dyspnea Scale (mMRC). The mMRC
scale (Doherty,2006) is a modified version of the original MRCDS (Fletcher et al.,
1959) which utilizes the same descriptors as the original MRC scale. Specifically,
the mMRC scale has descriptors numbered from 0-4 and is used for calculation of
BODE index (Munari et al., 2018). The mMRC has been validated to assess the
dyspneic symptoms of chronic obstructive pulmonary disease (COPD) (Munari et
al., 2018). Since COVID-19 and COPD patients each suffer from dyspnea,
(Beauchamp et al., 2010; O’Donnell, 2006; Shi et al., 2020) it is reasonable to use
this scale/questionnaire to assess the impact of COVID-19 on the lungs among the
survivors of this disease, although it has not been validated specifically for COVID19 survivors. The mMRC has shown to be superior compared to COPD assessment
test (CAT) in predicting the level of physical activity in a daily life (PADL, a
measure that is associated with lung function) among COPD patients (Munari et
al., 2018). The minimal clinical importance difference (MCID) value for this scale
was reported as 0.5 unit when it was used to monitor improvement after 3 weeks of
pharmacological treatment in patients with acute exacerbations of COPD (Araújo
Oliveira et al., 2017).
The International Physical Activity Questionnaire (IPAQ). The IPAQ
(Deng et al., 2006) was used to obtain internationally comparable data on healthrelated physical activity. The IPAQ (short, self-administered methods) contains 7
questions related to 3 categories of moderate, high, and vigorous activity levels. For
IPAQ scoring, the total MET-minutes/week was calculated as walk
(METs=3.3×min×days) + moderate activity (METs=4.0×min×days) + vigorous
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activity (METs=8×min×days) (Deng et al., 2006). Since COVID-19 infected
individuals usually experience symptoms such as general weakness, chest tightness
and dyspnea (Huang et al., 2020; Ora et al., 2020; Ren et al., 2020; Shi et al., 2020;
Zhang et al., 2020) and these can negatively affect the ability of these individuals
to perform physical activity, it is rational to utilize this questionnaire for the purpose
of assessing the ability for performing physical activity. Validity of the moderate
and vigorous activity portions were reported as (r = .430–.557) and (r = .702) for
sedentary behaviours during the weekdays among older adults (Cleland et al.,
2018). MCID values were not available for IPAQ at the time of writing this
research.
The Functional Status Questionnaire (FSQ). The FSQ (Jette et al., 1986) is
a short-self-administered questionnaire used for functional assessment of
ambulatory patients seen in primary care. It provides comprehensive information
related to patient's physical function in the activities of daily living, psychological,
social and role functions and variety of performance measures. This questionnaire
is designed for initial screening of disability and for monitoring meaningful changes
in patients’ clinical status over time. It was developed by groups of researchers from
Boston's Beth Israel Hospital and the University of California at Los Angeles. We
selected this questionnaire because it provides useful information about an array of
physical and psychosocial parameters that get unfavorably affected in individuals
infected with COVID-19 (Bohmwald et al., 2018; Huang et al., 2020; Ora et al.,
2020; Ren et al., 2020; Shi et al., 2020; Zhang et al., 2020). In a reliability study,
the six scales in this questionnaire achieved internal consistency ranging from 0.64
to 0.82 (Jette et al., 1986). MCID values were not available for the FSQ at the time
of writing this research.
The RAND-36 measure of health-related quality of life questionnaire. The
RAND-36 (Hays et al., 2016) is a widely used generic health related quality of life
(HRQoL) survey instrument. It includes 36 items which evaluates eight health
related concepts: physical functioning, role limitations caused by physical health
problems, energy/fatigue, pain, emotional wellbeing, role limitations caused by
emotional problems, social functioning, and general health perceptions. In addition,
this questionnaire is a profile that provides two summary scores for physical and
mental health (Hays et al., 2016). The rationale behind using this questionnaire was
due it offering valuable data about parameters that FSQ did not cover; such as
energy/fatigue, pain, emotional wellbeing that adversely affected in infected people
with COVID-19 (Huang et al., 2020; Mechanisms, 2019; Mullen et al., 2011; Ora
et al., 2020; Ren et al., 2020; Shi et al., 2020; Sun et al., 2020; Zhang et al., 2020).
This questionnaire was scored by linear transformation of each item to a 0–100
range (% of total possible score) and averaged (Hays et al., 2016)]. The MCID
values for this questionnaire’s eight parameters were reported as (10, 12.5, 12.5,
10, 10, 8.3, 12.5, and 10 point/100) for the physical functioning, role limitations
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caused by physical health problems, energy/fatigue, pain, emotional wellbeing, role
limitations caused by emotional problems, social functioning, and general health
perceptions, respectively when it was utilized to detect improvements in COPD
patients (Wyrwich et al., 2005).
Statistical analyses
Statistical analyses were be performed using SPSS version 26 (IBM Corp.,
Armonk, New York, USA). Demographic data was presented as mean and SD.
Non-parametric data obtained for the questionnaires and demographics are reported
as medians, ranges, interquartile range (IQR) and percentages. A Mann-Whitney
test was used to compare the variable data between the two groups. Statistical
significance was determined when p < 0.05.
Results
One hundred and eighty-eight individuals accessed the survey over the
period of 2 months (between October and December 2020). Participants with
incomplete responses were excluded leaving 39 COVID-19 infected and 75 healthy
controls. From the healthy control group, 39 control participants were randomly
selected based on age matching (Table 1). The percentage of males vs females were
18% versus 82% and 25% versus 75% in the IC and HC groups, respectively. The
dates of infection of the participants in the experimental group occurred between
January 2 and November 23, 2020. The average recovery period was (187 ± 88
days) from the date of infection till the date of taking the survey by infected
participants. Nine of these participants were hospitalized (hospitalization periods
ranged from 1-14 days, only 2 participants were in ICU for 4 and 23 days) while
the other 30 were not hospitalized. All hospitalized participants confirmed that they
were hospitalized as a result of being infected with COVID-19. The final sample
size for the RAND-36 (HRQoL) questionnaire, however, was 76 participants (38
participants for each group) due to an incomplete response by a participant in the
infected group.

Published by NSUWorks, 2020

5

NeuroSports, Vol. 1, Iss. 1 [2020], Art. 10

Table 1. Demographics information for the CI and HC groups presented as mean
and SD values.
Demographics
Age/yrs.

CI
n = 39 & 38
47.4 ±8.2

HC
n = 39 & 38
46.1 ±9.0

Weight/kg

77.6 ±14.9

79.5 ±24.6

Height/cm
169.2 ±8.7
CI: COVID-19 infected, HC: Healthy control.

167.3 ±9.0

Mann-Whitney test indicated that there were no significant differences in
age, weight, and height between the HC and CI groups. As for mMRC, CI group
scored significantly higher than HC group (Table 2 and Fig. 1).
Table 2. Demographics of the participants and the results of dyspnea scale of the
mMRC in CI (n=39) and HC (n=39) groups.
Variable

CI
HC median U value
p value
r
median
Age (yrs.)
48
46
659.5
= 0.312
.11
Weight (kg)
77
80
696.5
= 0.522
.07
Height (cm)
168
167
608.0
= 0.125
.17
mMRC (scores) 2
0
163.0
< 0.001
.74
Data are presented as median, U, p, and r values. Mann-Whitney test was
used to explore statistically significant differences between the two groups.
Modified Medical Research Council: mMRC, CI: COVID-19 infected, HC:
Healthy control.
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Fig. 1 Demographics of the participants and the results of dyspnea scale of
the mMRC in CI (n=39) and HC (n=39) groups.

Boundaries of the figures represent, median, minimum, maximum, 25th and 75th
percentiles, and the sign • indicates outliers. Mann-Whitney test was used to
explore statistically significant differences between the two groups. HC: Modified
Medical Research Council: mMRC, CI: COVID-19 infected, HC: Healthy control.
In the IPAQ questionnaire, the CI group scored significantly lower than the
HC group in vigorous, moderate, and combined physical activity scores. However,
there were no significant differences between the groups for walking and sitting
parameters (Table 3 and Fig 2).
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Table 3. The outcome scores of the IPAQ parameters for CI (n=39) and HC (n=39)
groups.
Variable

CI
median
PA 0

Vigorous
(min/MET/wk)
Moderate
PA 0
(min/MET/wk)
Combined
PA 594
(min/MET/wk)
Walking (min/MET/wk) 303

HC
median
1200

U value

p value

r

314.0

< 0.001

.54

540

291.5

< 0.001

.54

2845

375.5

< 0.001

.44

693

597.5

=
.19
0.102
Sitting (min/wk)
480
360
583.5
= 0.075 .20
Data are presented as median, U, p, and r values. Mann-Whitney test was
used to explore statistically significant differences between the two groups. IPAQ:
International Physical Activity Questionnaire. CI: COVID-19 infected, HC:
Healthy control, PA: physical activity
The CI group scored significantly lower than HC group in basic ADL,
intermediate ADL, mental health, work performance, social activities, and quality
of interactions parameters of FSQ (Table 4 and Fig 3). As for the single items
included in the FSQ, (Table 5) shows the results for both groups as percentages.
In the RAND-36 HRQoL questionnaire, the CI group reported lower scores
compared to HC group in physical functioning, role limitations due to physical
health, role limitations due to emotional problems, energy/fatigue, emotional wellbeing, social functioning, pain, and general health parameters (Table 6 and Fig 4).
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Fig. 2 The outcome scores of the IPAQ parameters for CI (n=39) and HC
(n=39) groups.

Boundaries of the figures represent, median, minimum, maximum, 25th and 75th
percentiles, and the sign • indicates outliers. Mann-Whitney test was used to
explore statistically significant differences between the two groups. IPAQ:
International Physical Activity Questionnaire. CI: COVID-19 infected, HC:
Healthy control, Vig. PA: vigorous physical activity, Mod. PA: moderate physical
activity.
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Table 4. The outcome scores of the FSQ parameters for CI (n=39) and HC
(n=39) groups.
Variable
CI
HC
U value p value
r
100 point/scale
median
median
Basic ADL
89
100
338.0
< 0.001
.52
Intermediate ADL
44
100
115.5
= 0.001
.74
Mental health
56
72
413.5
< 0.001
.39
Work performance
39
100
108.5
= 0.044
.74
Social activities
0
33
560.5
= 0.001
.22
Quality of interactions
47
60
419.5
= 0.001
.38
Data are presented as median, U, p, and r values. Mann-Whitney test was
used to explore statistically significant differences between the two groups.
ADL, activities of daily living, FSQ: Functional Status Questionnaire, CI:
COVID-19 infected, HC: Healthy control.
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Fig. 3 The outcome scores of the FSQ parameters for CI (n=39) and HC
(n=39) groups.

Boundaries of the figures represent, median, minimum, maximum, 25th and 75th
percentiles, and the sign • indicates outliers. Mann-Whitney test was used to
explore statistically significant differences between the two groups. FSQ:
Functional Status Questionnaire, CI: COVID-19 infected, HC: Healthy control.
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Table 5. Single items’ results of the Functional Status Questionnaire in CI and HC
groups presented as percentages.
Single Items
1- Work Working full-time
situation Working part-time
Unemployed looking for work
Unemployed because of my health
Retired because of my health
Retired for some other reason

CI

HC

25.6 %
17.9 %
2.5 %
33.3 %
5.1 %
15.4 %

66.6 %
20.5 %
2.5 %
5.1 %
0.0 %
5.1 %

2- During the past month, how many days did
26.4%
2.8%
illness or injury keep you in bed all or most of out 31-day out 31-day
the time?
period
period
3- you cut down on the things you usually do 66.7%
8.7%
for one-half day or more because of your illness out 31-day out 31-day
or injury?
period
period
4- During the past month,
how satisfied were you
with
your
sexual
relationships?

Very satisfied
Satisfied
Not sure
Dissatisfied
Very dissatisfied
Did not have any
sexual
relationships.

5- How do you feel about Very satisfied
your health?
Satisfied
Not sure
Dissatisfied
Very dissatisfied

2.6%
15.4%
5.1%
10.3%
15.4%
51.3%

10.3%
41.0%
10.3%
20.5%
0.0%
17.9%

0.0%
7.7%
10.3%
20.5%
61.5%

23.1%
56.4%
5.1%
12.8%
2.6%

6- During the past month, Every day
about how often did you Several times /wk.

https://nsuworks.nova.edu/neurosports/vol1/iss1/10
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get together with friends
or relatives, such as going
out together, visiting in
each other's home, or
talking on the telephone?

About once /wk.

17.9%

10.3%

2 or 3 times a 28.2%
month
About 1 a month
12.8%
Not at all
17.9%

30.8%
10.3%
17.9%

CI: COVID-19 infected, HC: Healthy control.

Table 6. The outcome scores of the RAND-36 questionnaire (HRQoL) parameters
CI (n=38) and HC (n=38) groups.
Variable
CI
HC
U value
p value
r
100 point/scale
median median
Physical functioning
45
100
116.0
< 0.001
.74
Role limitation due to 0
100
106.5
< 0.001
.79
physical health
Role limitations due to 0
100
392.0
< 0.001
.42
emotional problems
Energy/fatigue
13
58
187.5
< 0.001
.64
Emotional well-being
60
76
469.5
= 0.009
.30
Social functioning
50
88
264.0
< 0.001
.55
Pain
45
90
181.5
< 0.001
.65
General health
35
80
135.0
< 0.001
.70
Data are presented as median, U, p, and r values. Mann-Whitney test was used to
explore statistically significant differences between the two groups. HRQoL:
Health related quality of life, CI: COVID-19 infected HC: Healthy control.
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Fig. 4 The outcome scores of the RAND-36 questionnaire (HRQoL) parameters CI
(n=38) and HC (n=38) groups.

Boundaries of the figures represent, median, minimum, maximum, 25th and 75th
percentiles, and the sign • indicates outliers. Mann-Whitney test was used to
explore statistically significant differences between the two groups. HRQoL:
Health related quality of life, HC: Healthy control, CI: COVID-19 infected.
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Discussion
We sought to determine the differences in quality of life, physical activities,
functional performance, and symptoms of dyspnea between individuals previously
infected with COVID-19 and age-matched healthy individuals. Our novel findings
are that: 1) dyspnea was greater in the COVID-19 infected group compared to the
healthy control group; and 2) outcomes related to the questionnaires of IPAQ
(measures walking, moderate, vigorous and combined activity levels), FSQ
(measures physical function in the ADL, psychological, social and role functions
and variety of performance measures ), and RAND-36 HRQoL (measures physical
functioning, role limitations caused by physical health problems, energy/fatigue,
pain, emotional wellbeing, role limitations caused by emotional problems, social
functioning, and general health perceptions) in the CI group were significantly
lower than the scores achieved by the HC group. Interestingly, we found no
significant differences in sitting and walking activity scores for IPAQ between the
two groups. Together, our findings suggest that COVID-19 infected individuals
experience higher levels of dyspnea and reduction in quality of life, functional
status, and moderate to vigorous physical activities following recovery from
COVID-19 infection.
The results of dyspnea scale of the mMRC showed that the CI group had
significantly higher scores than the HC group (M = 1.77 vs 0.13). Further, in CI
group, 33 out 39 experienced different levels of dyspnea vs only 3 out of 39 in HC
group. The findings of our study are in agreement with what is reported by Wu and
colleagues stating that exertional dyspnea was one of the common symptoms even
after 6 months of discharge from hospital among the survivors of the virus (Q. Wu
et al., 2021). Raman et al. (2021), also indicated that 64% and 55% of the recovered
patients experienced dyspnea, after 2-3 months from the infection date with the
virus (Raman et al., 2021). Based on our study results and those of others (Fayol et
al., 2021; Raman et al., 2021; Q. Wu et al., 2021), it is important to emphasize
dyspnea as one of the most common symptoms among the COVID-19 infected
individuals. Therefore, addressing dyspnea should be one of the primary goals in
any long-term rehabilitation programs designed for the individuals who survived
the COVID-19 infection.
The IPAQ results showed that the CI group achieved significantly lower
scores than the HC group in vigorous (by ≈ 200%), moderate (by ≈ 260%), and
combined physical activities (by ≈180%), but not in sitting and walking activity.
The lower scores achieved by the CI group might have occurred due to several
factors: dyspnea/chest tightness, fatigue, and/or general weakness (Fayol et al.,
2021; Raman et al., 2021; Q. Wu et al., 2021). The lack of significant differences
in our study between the CI and the HC groups for walking and sitting scores could
be due to the COVID-19 pandemic itself. To slow infection rates of COVID-19,
most of the authorities and governments around the world applied policies such
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shelter in place, lock downs, and extensive social distancing (Hossain et al., 2020)
which, in turn, significantly lowered outdoor physical activities such as walking
and increased the hours of sitting at home. A study examining the effects of
COVID-19 home confinement on physical activity and eating behavior showed that
home confinement had a noticeable deleterious effect on all intensities of physical
activities and walking as well as increasing daily sitting time from 5 to 8 hours per
day (Ammar et al., 2020). Despite that the pandemic negatively affected all physical
activity intensities performed by people world-wide as reported by Ammar and his
colleagues, our study was able to show significant differences between HC and CI
groups in vigorous and moderate physical activity scores favoring HC group. This
could be because our study was conducted during the end of the first year of the
pandemic unlike the study conducted by Ammar and colleagues after passing the
first 3-4 months of the pandemic. During the end of 2020, people were informed
more about the importance of performing physical activities and follow the
guidelines to prevent the spread of the virus. This crucial up-to-date information
came from national/local authorities, healthcare systems and media (Natalucci et
al., 2020).
In the FSQ, the CI group scored significantly lower than the HC group in
all parameters within this questionnaire. The lower scores for basic (by ≈ 18%),
intermediate ADL (by ≈ 93%) and work performance (by ≈ 260%) in the CI group
may resulted from symptoms commonly experienced in individuals infected with
this virus, symptoms such as dyspnea/chest tightness, fatigue (Fayol et al., 2021;
Raman et al., 2021; Q. Wu et al., 2021).These results have important potential
implications on rehabilitation of the survivors of this virus. Improving intermediate
ADL and work performance may take longer than just a few rehabilitation visits to
address the basic physical activity needs. Furthermore, the recovery time of CI
participants varied from 1 to ≈ 11 month before participating in our study, yet they
had significant persisting reduction in quality of life, functional status, and
moderate to vigorous physical activity compared to aged-matched healthy
individuals. Poor scores in mental health, social activities and quality of interactions
parameters of FSQ in CI group might be due to certain long-lasting
psychopathological negative consequences that are commonly associated with
respiratory viral infectious diseases (Cheng et al., 2004). Other factors that might
reflect these poor scores could be social isolation, stigma, fear of disease, future
insecurity, and traumatic experiences of severe illness during the infection with
COVID-19 (Mechanisms, 2019; Sun et al., 2020). Furthermore, several studies
reported that SARS survivors present with psychiatric symptoms such as obsessivecompulsive disorder (OCD), panic disorder, depression, and post-traumatic stress
disorder (PTSD) (Cheng et al., 2004; Sun et al., 2020; Y. Wu et al., 2020). Mazza
et al. (2020) also indicated that COVID-19 survivors (n = 402) presented with OCD,
PTSD, depression, insomnia, and anxiety symptoms after a month of being
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discharged from treatment in the hospital. Results here also give the multidisciplinary rehabilitation professionals the chance to tailor their interventions to
meet the specific needs of COVID-19 survivors. This can be as easy as encouraging
survivors to connect with friends and extended family members through social
media, virtual meetings a gathering outdoors while maintaining appropriate
physical distancing to prevent the spread of the virus during the time of this
pandemic.
Single item questions in FSQ showed noticeable differences in work
situation, number of days illness kept the person in bed and cutting down on the
things a person usually does for one-half day or more because of illness or injury
during the past month, satisfaction of sexual relationships, and the feeling of overall
health favoring HC group over CI group. These findings could be due to the
physical and the psychological symptoms associated with being infected with
COVID-19 (Fayol et al., 2021; Halpin et al., 2021; Mullen et al., 2011; Raman et
al., 2021; Sun et al., 2020; Wyrwich et al., 2005). Furthermore, COVID-19 may
show some manifestations that can adversely affect patient's sexual drive and/or
deter the partner from having any sexual relationship despite the full recovery of
the their partners from the illness (Abbas et al., 2020). The social activities item
discussing getting together with friends or relatives, going out, visiting in each
other's home, or talking on the telephone resulted in similar percentages between
both groups. This similarity could be due to the social distancing and lockdown
policies that affected everyone (i.e., infected and non-infected individuals)
worldwide (Hossain et al., 2020).
The RAND-36 HRQoL questionnaire scores showed that the CI group
scored significantly lower than the HC group in physical functioning, role
limitations due to physical health, role limitations due emotional problems,
energy/fatigue, emotional well-being, social functioning, pain, and general health
parameters. Our findings here too are in agreement with several studies that
reported persisting symptoms related to the parameters in this questionnaire (Cheng
et al., 2004; Fayol et al., 2021; Mechanisms, 2019; Raman et al., 2021; Sun et al.,
2020; Q. Wu et al., 2021; Y. Wu et al., 2020). Ren et al. (Ren et al., 2020), and
other investigators (Mechanisms, 2019; Sun et al., 2020) found that muscle pain
(i.e., myalgia) and soreness which is commonly mediated by Interleukin-6 (IL-6) is
the most common cause (36% of patients) of pain among COVID-19 survivors
specifically at the first the onset of the infection with the virus (Li et al., 2020;
Mechanisms, 2019; Sun et al., 2020). It has been also reported that infected
individuals of COVID-19 presented with persistent chest pain, fatigue, myalgia,
cognitive impairment, as well as anxiety, depression, sleep disturbances and PTSD
during the post-acute phase of COVID-19 infection (Nalbandian et al., 2021). The
isolation that is required as a result of being infected with COVID-19 may certainly
cause an increased stress and anxiety which, in turn, can worsen the perception of
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pain among other symptoms in these individuals (Mazza et al., 2020). The results
of the RAND-36 HRQoL questionnaire in this study further signifies its
implications on professionals in all levels of the multi-disciplinary rehabilitation
programs. Addressing the physical deficiencies and related social and emotional
concerns should be the primary focus areas in rehabilitation for COVID-19
survivors. Also, educating these individuals about the short- and long-term effects
of this virus on their bodies would be an appropriate approach to address future
uncertainty and anxiety concerns. Further, encouraging survivors to keep in touch
with family and loved ones via virtual meetings and safe gathering outdoors may
also help in the process of long-term rehabilitation.
We investigated the multifaceted impacts of post-acute phase of COVID19 infection on the sense of dyspnea, select physical, functional, and psychological
variables among survivors compared to age matched healthy participants and their
implications for rehabilitation programs in this population. One of the strengths of
this study is the age matched healthy control group, which provides robustness by
comparing results from the CI patients with matched HC. Another strength is the
use of 4 standardized, validated questionnaires to collect data about physical and
psychosocial parameters among HC and CI groups. Although we did not perform
any lab-based tests, the questionnaires used in this study covered a wide spectrum
of important physical, functional, and psychosocial important parameters.
Furthermore, providing online questionnaires for the participants ensured their
safety from getting exposed to the virus again. Additionally, non-Canadian
participants formed 23% of the total number of the participants. Though this a
percentage is small, however, it is still considered a strength for this study given
that the experience between the Canadians, Americans, and citizens of other
countries maybe was different (Yoo et al., 2020).
Our study was not without limitations. While we have assessed the survey
responses of the individuals based on their symptoms and status at the time of
completing the survey, we do not have data measuring their pre-COVID status, nor
their change in status since infection. It is possible that our data capture merely a
snapshot in time, and do not account for pre-COVID concerns. For example, in the
CI group, differences in pre-COVID physical activity, pre-existing co-morbidities,
or psychological concerns may have impacted the severity and/or duration of
symptoms. For the HC group, these differences may mean the ‘pandemic
influenced’ responses may be quite different than their normal responses. While
these factors may alter the differences observed between the CI and HC groups, we
believe this snapshot at the point of survey completion reflects the reality of
pandemic-related changes that may have occurred in both groups. Another
limitation of this study is that the participants in CI group were only matched by
age, and not gender, with the participants in HC group. Because of the timesensitive nature of this research during the COVID-19 pandemic, we limited
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recruitment to a 2-month period which limited the number of participants we could
recruit. It is possible that the results of our study do not adequately account for
gender-related differences. The date of the infection of COVID-19 survivors ranged
from 1 to ≈ 11 month which lends to a varied recovery time. This large variation in
recovery time occurred because of our limited recruitment window due to the timesensitive nature of the research as described above. Therefore, to maximize
potential recruitment, we opened the inclusion to anyone who had symptoms
beyond 28 days from the date of infection. Despite this, the average period of (187
± 88 days) from the time of infection until the date of taking the survey provides
valuable information about the extent of the persisting nature of these limitations
during the post-acute phase of the illness. In addition, we did not notice any trend
indicating that the participants who were infected in earlier dates (i.e., long time
before the survey date) had different symptoms than the participants who were
infected in later dates (i.e., closer to survey date); however, it is possible that our
sample was not large enough to capture any differences. The severity of illness
during infection was determined only be self-report, and therefore, it may be
difficult to generalize our findings to all COVID-19 survivors. In addition, small
number (9 out of 39) of the infected participants have been hospitalized while the
others never been hospitalized due to being infected with the virus. Consequently,
most of the infected participants in this study can be considered mild cases.
However, it is important to acknowledge that the vast majority of patients affected
by COVID-19 were not ever hospitalized. Further, this study had only 2
hospitalized participants who were admitted to ICU due to being infected with
COVID-19, therefore, we suggest that the infected sample of participants in our
study does not represent individuals who are more severely affected by COVID-19
illness.
We report that COVID-19 survivorship is associated with ongoing
functional and psychological deficits. Scores of dyspnea in the CI group were
significantly higher than in the HC group. Scores of the vigorous, moderate, and
combined physical activities were significantly lower in the CI group than in the
HC group but both groups achieved similar scores for sitting and walking activity.
Scores related to quality of life, functional status, psychosocial and emotional
parameters within both FSQ and RAND-36 HRQoL questionnaires also showed
that the CI group achieved significantly lower than the HC group. Further research
is needed to better understand the reasons for these negative impacts of COVID-19
on the survivors. These studies can focus on more lab-based testing for the
cardiopulmonary, neuromuscular systems and or to study the pace of recovery
among the COVID-19 survivors.
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Clinical messages
1- Persistent dyspnea, declined moderate to vigorous physical activity,
functional status and quality of life parameters were noticed after an
average of 6 months of infection date with COVID-19.
2- Majority of the infected cases in this study can be categorized as mild
cases since they were never hospitalized.
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